Growth Metrics

Valion Bio (TIVC) Change in Inventory (2021 - 2025)

Valion Bio has reported Change in Inventory over the past 5 years, most recently at -$16.2 million for Q4 2025.

  • For Q4 2025, Change in Inventory fell 179744.44% year-over-year to -$16.2 million; the TTM value through Dec 2025 reached -$16.3 million, changed N/A, while the annual FY2025 figure was -$16.3 million, N/A changed from the prior year.
  • Change in Inventory for Q4 2025 was -$16.2 million at Valion Bio, down from -$49000.0 in the prior quarter.
  • Over five years, Change in Inventory peaked at $386000.0 in Q2 2022 and troughed at -$16.2 million in Q4 2025.
  • A 5-year average of -$827000.0 and a median of $9000.0 in 2024 define the central range for Change in Inventory.
  • Biggest five-year swings in Change in Inventory: skyrocketed 687.76% in 2022 and later plummeted 179744.44% in 2025.
  • Year by year, Change in Inventory stood at $139000.0 in 2021, then dropped by 26.62% to $102000.0 in 2022, then tumbled by 237.25% to -$140000.0 in 2023, then skyrocketed by 106.43% to $9000.0 in 2024, then plummeted by 179744.44% to -$16.2 million in 2025.
  • Business Quant data shows Change in Inventory for TIVC at -$16.2 million in Q4 2025, -$49000.0 in Q3 2025, and -$23000.0 in Q2 2025.